Top compounds associated with response to RBP2


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.031 0.4
mRNA AKT inhibitor VIII GDSC1000 pan-cancer AAC -0.03 0.4
mRNA DBeQ CTRPv2 pan-cancer AAC 0.03 0.4
mRNA YM201636 GDSC1000 pan-cancer AAC -0.027 0.4
mRNA ibrutinib CTRPv2 pan-cancer AAC 0.034 0.4
mRNA Cytarabine CTRPv2 pan-cancer AAC -0.023 0.4
mRNA Topotecan CTRPv2 pan-cancer AAC -0.026 0.4
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.03 0.4
mRNA lovastatin CTRPv2 pan-cancer AAC 0.03 0.4
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.041 0.4
Download CSV